Evidence map›Paper›PMID 38023363›Full record

ArticleExperimental and therapeutic medicine2023

IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia

Wei Zhou, Qigang Dai, Ning Su, Zhihui Liu, Jinxing Hu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. IGF2BP2: an mCellular & molecular biology letters · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wei ZhouDepartment of Pathology, Guangzhou Chest Hospital, Guangzhou, Guangdong 510095, P.R. China.
Qigang DaiDepartment of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510699, P.R. China.
Ning SuDepartment of Oncology, Guangzhou Chest Hospital, Guangzhou, Guangdong 510095, P.R. China.
Zhihui LiuDepartment of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, Guangdong 510095, P.R. China.
Jinxing HuDepartment of Tuberculosis, Guangzhou Chest Hospital, Guangzhou, Guangdong 510095, P.R. China.
Guangzhou Chest Hospital · CNFirst Affiliated Hospital of Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumonia is a disease caused by inflammation and has high morbidity and mortality rates. Stromal interaction molecule 1 (

Indexed as

endoplasmic reticulum stressIGF2BP2inflammatory responsepneumoniaSTIM1

Identifiers

PMID38023363
PMCPMC10652236
OpenAlexW4388204107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.